MedTrace Logo

Continuous Renal Replacement Therapy With Oxiris in Acute Kidney Injury and Sepsis

NCT06253377 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-02-12

No results posted yet for this study

Summary

It is an epidemiology study to explore outcomes in patients with acute kidney injury (AKI) and sepsis submitted to continuous renal replacement therapy (CRRT) with Oxiris™.

Objectives:

Describe the experience and outcomes in patients with sepsis and AKI treated receiving CRRT with the adsorption membrane filter Oxiris™

Conditions

Interventions

DEVICE

Adsorption membrane filter Oxiris™

Continuous Renal Replacement Therapy with the adsorption membrane filter Oxiris™

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Nefro Consultoria de Doenças Renais Ltda

    lead NETWORK

Principal Investigators

  • Elisabeth R Maccariello, MD, PhD · Nefro Consultoria de Doenças Renais

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-08
Primary Completion
2024-10-31
Completion
2025-04-30
FDA Device
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06253377 on ClinicalTrials.gov